Sign in →

Test ID BLOD0311 CA 15-3

Synonym

CA 15-3 (Breast Cancer), BR Monitor

Specimen Type/Requirements

Gold top (serum w/gel) tube - Serum (preferred)

Red top (serum w/out gel) tube - Serum

Light Green top (Lithium Heparin w/gel) tube - Plasma

 

Specimen should be centrifuged and separated within 2 hours of collection.

 

Test may be affected by gross hemolysis, gross icterus and gross lipemia.

Specimen Volume

 Preferred Volume     1.0 mL   
 Minimum Volume     0.5 mL

Stability/Transport

 Room Temperature     24 hours     
 Refrigerated     7 days     Preferred for transport   
 Frozen     1 year     

Performed Test Frequency

Monday - Sunday

Report Available

1 - 3 days

Additional Information

This test is used for management of Breast Cancer.

Methodology

Chemiluminescence

CA 15-3 values obtained from different assay methods cannot be used interchangeably.

Performing Lab

Sanford Laboratories Sioux Falls, Fargo, Bismarck

CPT

86300

Coverage Limitations

This test has limited coverage - please submit Commercial Insurance Patient Waiver (Non-Medicare) if applicable.

Interface Build Information

SANFORD LABORATORY INTERFACE BUILD INFORMATION

 Result Code     Result Code Description   
 17083  CA 15-3